| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $16.99B | $12.39B | $10.05B |
| YoY Revenue Growth % | +37.2% | +23.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.02B | $1.25B | $1.26B |
| Operating Margin % | 6.0% | 10.1% | 12.5% |
| Net Income (GAAP) | $863.0M | $1.06B | $1.07B |
| EBITDA (Normalized) | $1.47B | $1.70B | $1.62B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$411.4M | $277.6M | $512.6M |
| Capital Expenditures (CapEx) | $570.4M | $562.5M | $452.4M |
| Free Cash Flow (FCF) | -$981.8M | -$284.9M | $60.2M |
| FCF Margin % | -5.8% | -2.3% | 0.6% |
| Return on Invested Capital (ROIC %) | 7.9% | 14.9% | 13.6% |
| Cash & Short-Term Equivalents | $1.04B | $967.1M | — |
| Total Debt (Short + Long Term) | $5.92B | $4.67B | $2.83B |
| Total Stockholders' Equity | $5.34B | $2.93B | $5.81B |